Dana C Miskulin
Affiliation: Tufts Medical Center
- Intravenous iron exposure and mortality in patients on hemodialysisDana C Miskulin
Due to the number of contributing authors, the affiliations are provided in the Supplemental Material
Clin J Am Soc Nephrol 9:1930-9. 2014..The associations between short- and long-term iron exposure on all-cause and cause-specific mortality were examined...
- Patterns in blood pressure medication use in US incident dialysis patients over the first 6 monthsWendy L St Peter
University of Minnesota College of Pharmacy, Minneapolis, MN, USA
BMC Nephrol 14:249. 2013....
- Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional studyDana C Miskulin
Tufts Medical Center, Boston, MA Electronic address
Am J Kidney Dis 63:214-26. 2014..We hypothesized that increased TKV would be a source of morbidity and diminished quality of life that would be worse in patients with more advanced disease...
- Trends in anemia management in US hemodialysis patients 2004-2010Dana C Miskulin
Division of Nephrology, Tufts University School of Medicine, Boston, MA, USA
BMC Nephrol 14:264. 2013..There have been major changes in the management of anemia in US hemodialysis patients in recent years. We sought to determine the influence of clinical trial results, safety regulations, and changes in reimbursement policy on practice...
- Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease studyL Ebony Boulware
Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, 2024 E, Monument Street, Baltimore, MD 21205, USA
BMC Nephrol 13:167. 2012..Evidence is lacking to inform providers' and patients' decisions about many common treatment strategies for patients with end stage renal disease (ESRD)...
- Key comorbid conditions that are predictive of survival among hemodialysis patientsDana Miskulin
Division of Nephrology, Tufts Medical Center, 800 Washington Street, Box 391, Boston, MA 02111, USA
Clin J Am Soc Nephrol 4:1818-26. 2009..We sought to determine which conditions are most prognostic and whether comorbidity continues to contribute to a survival model once laboratory and clinical parameters have been accounted for...
- Computerized decision support for EPO dosing in hemodialysis patientsDana C Miskulin
Tufts Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 54:1081-8. 2009..The present study explored the hypothesis that computerized dosing of intravenous erythropoietin (EPO) would increase the percentage of hemoglobin (Hb) values within the target range and reduce staff time spent on anemia management...
- Comorbidity and its change predict survival in incident dialysis patientsDana C Miskulin
Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 41:149-61. 2003..Longitudinal change in the comorbid illness burden of incident dialysis patients has not been measured. Comorbidity severity and its change may serve as important prognostic markers of survival, independent of other case-mix factors...
- Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instrumentsDana C Miskulin
Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
Nephrol Dial Transplant 19:413-20. 2004..We compare the discriminatory accuracy of 1 year mortality predictions derived from four comorbidity instruments in a large representative US dialysis population...
- Reducing versus discontinuing erythropoietin at high hemoglobin levelsDaniel E Weiner
Division of Nephrology, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
J Am Soc Nephrol 18:3184-91. 2007....
- Nadir hemoglobin levels after discontinuation of epoetin in hemodialysis patientsJose A Calvo
Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA
Clin J Am Soc Nephrol 5:1621-7. 2010..In hemodialysis patients, both hemoglobin variability and targeting normalization of hemoglobin may have adverse consequences. There are few data on epoetin management in patients achieving high hemoglobin levels...
- Temporal trends in health-related quality of life among hemodialysis patients in the United StatesEzra Gabbay
William B Schwartz Division of Nephrology, Tufts Medical Center, Boston, Massachusetts 02111, USA
Clin J Am Soc Nephrol 5:261-7. 2010..Health-related quality of life (HRQOL) is a measure of the well being of hemodialysis patients and an independent prognostic predictor. Our aim was to determine whether HRQOL among hemodialysis patients has changed over time...
- Variation in fistula use across dialysis facilities: is it explained by case-mix?Navdeep Tangri
Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA
Clin J Am Soc Nephrol 5:307-13. 2010..This study aimed to determine the magnitude of the variability in AVF usage across dialysis facilities and the extent to which patient case-mix explains it...
- Demographics and trends in overweight and obesity in patients at time of kidney transplantationAllon N Friedman
Division of Nephrology, Indiana University School of Medicine, Indianapolis, IN, USA
Am J Kidney Dis 41:480-7. 2003..The authors describe the prevalence, demographics, and trends in overweight and obesity at the time of kidney transplantation...
- Updated comorbidity assessments and outcomes in prevalent hemodialysis patientsTara I Chang
Division of Nephrology, Stanford University School of Medicine, Palo Alto, California, USA
Hemodial Int 14:478-85. 2010..Updated assessments of comorbidity significantly strengthen the ability to predict death in patients on hemodialysis. Future studies in dialysis should invest the necessary resources to include repeated assessments of comorbidity...
- Satisfaction with Care of Patients on HemodialysisMichelle M Richardson
William B Schwartz Division of Nephrology, Tufts Medical Center, Boston, Massachusetts Dialysis Clinic, Inc, Outcomes Monitoring Program, Boston, Massachusetts
Clin J Am Soc Nephrol 10:1428-34. 2015..This study examined factors predicting response to Dialysis Clinic, Inc. (DCI)'s patient satisfaction survey and factors associated with higher satisfaction among responders...
- Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal DiseaseDana C Miskulin
Division of Nephrology, New England Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 39:324-36. 2002..Adjustment for case-mix differences in patients treated with PD versus HD is essential to the assessment of the independent effect of the dialysis modality on outcomes...
- Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom Renal RegistryNavdeep Tangri
Division of Nephrology, Tufts Medical Center, Boston MA 02111, USA
Am J Kidney Dis 57:415-21. 2011..However, whether achievement of these targets improves survival is unknown...
- Therapeutic Area Data Standards for Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC)Ronald D Perrone
Department of Medicine, Division of Nephrology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA Electronic address
Am J Kidney Dis 66:583-90. 2015....
- Making an earlier diagnosis of ADPKD: implications for the treatment of hypertensionRon Perrone
Tufts New England Medical Center, Boston, MA, USA
Nephrol News Issues 20:32, 35-6. 2006
- Case-Mix and its Effects on Quality Indicators in End Stage Renal DiseaseDana Miskulin; Fiscal Year: 2008..degree in Epidemiology and the career development program will build on the candidate's skills and experience to enable her to lead future studies to improve outcomes patients with chronic kidney disease ..